Cite

MLA Citation

    Jérémie Sellam et al.. “CCL19, a B Cell Chemokine, Is Related to the Decrease of Blood Memory B Cells and Predicts the Clinical Response to Rituximab in Patients With Rheumatoid Arthritis.” Arthritis and rheumatism, vol. 65, no. 9, n.d., pp. 2253–2261. http://access.bl.uk/ark:/81055/vdc_100178294680.0x00005b
  
Back to record